WallStreetZenWallStreetZen

NASDAQ: INKT
Mink Therapeutics Inc Stock Ownership - Who owns Mink Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mink Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ulf WiinbergDirector2026-09-011,279$10.95
$14.01kBuy
Barbara RyanDirector2026-09-011,622$10.95
$17.76kBuy
Peter BehnerDirector2026-09-011,485$10.95
$16.26kBuy
John Bradley HolcombDirector2026-09-011,233$10.95
$13.50kBuy
Brian CorveseDirector2026-09-011,633$10.95
$17.88kBuy
Barbara RyanDirector2026-06-041,000$12.80
$12.80kSell
Barbara RyanDirector2026-06-04500$12.68
$6.34kSell
John Bradley HolcombDirector2026-06-011,091$12.38
$13.51kBuy
Ulf WiinbergDirector2026-06-011,131$12.38
$14.00kBuy
Brian CorveseDirector2026-06-011,444$12.38
$17.88kBuy

1 of 4

INKT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INKT insiders and whales buy or sell their stock.

INKT Shareholders

What type of owners hold Mink Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Agenus Inc426.67%21,772,863$262.36MInsider
Garo H. Armen38.53%1,966,400$23.70MInsider
Ulf Wiinberg1.56%79,589$959.05kInsider
Jennifer Buell1.14%57,942$698.20kInsider
Christine M. Klaskin1.09%55,660$670.70kInsider
Brian Corvese1.07%54,770$659.98kInsider
John Baldoni0.81%41,193$496.38kInsider
Dijk Marcus Antonius Van0.54%27,363$329.72kInsider
Peter Behner0.48%24,404$294.07kInsider
Barbara Ryan0.46%23,591$284.27kInsider

1 of 3

INKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INKT0.00%100.00%Net BuyingNet Buying
FRMM0.02%99.98%Net SellingNet Selling
HYPD0.01%99.99%Net Buying
XLO0.01%99.99%Net Selling
EXOZ0.00%100.00%Net BuyingNet Buying
View Top Biotech Stocks

Mink Therapeutics Stock Ownership FAQ

Who owns Mink Therapeutics?

Mink Therapeutics (NASDAQ: INKT) is owned by 0.00% institutional shareholders, 472.82% Mink Therapeutics insiders, and 0.00% retail investors. Agenus Inc is the largest individual Mink Therapeutics shareholder, owning 21.77M shares representing 426.67% of the company. Agenus Inc's Mink Therapeutics shares are currently valued at $262.36M.

If you're new to stock investing, here's how to buy Mink Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.